|
Prescribing
Information for BIPI Marketed Products |
|
|||||
|
Product Name |
Version |
Current Prescribing Information |
|
|||
|
|
||||||
|
Aggrenox®
Capsules
|
May 2021 |
|||||
|
Aptivus®
Capsules and Oral Solution |
June 2020 |
|||||
|
Atrovent®
HFA Inhalation Aerosol |
February
2020 IT7036C |
|||||
|
Catapres®
Tablets |
August 2016 |
|||||
|
Combivent® Respimat®
|
December 2021 |
|
||||
|
Gilotrif®
Tablets |
April 2022 |
|
||||
|
Glyxambi®
Tablets |
March
2022 COL8994E |
|
||||
|
Jardiance® Tablets (empagliflozin) |
March 2022 COL8914F |
|
||||
|
Jentadueto®
Tablets |
April
2022 COL9414C |
|
|
|||
|
Jentadueto®
XR extended-release tablets |
October
2021 COL9394A |
|
||||
|
Micardis®
HCT Tablets
|
August 2020 |
|
||||
|
Micardis®
Tablets
|
July 2020 |
|
||||
|
Mirapex®
Tablets
|
July 2021 |
|
||||
|
Mirapex ER®
extended-release tablets
|
July 2021 |
|
|
|||
|
Mobic®
Tablets
|
April 2021 |
|
||||
|
Ofev®
Capsules |
January 2022 |
|
||||
|
Persantine
Tablets |
December 2019 |
|
||||
|
Pradaxa® Capsules (dabigatran etexilate) |
June 2021
|
|
||||
|
Pradaxa® Oral Pellets (dabigatran etexilate) |
March 2022
|
|
||||
|
Praxbind® Injection |
October 2021 COL10514A |
|
||||
|
Spevigo® Injection (spesolimab-sbzo) |
September 2022 COL9614A |
|
||||
|
Spiriva® |
November 2021 |
|
||||
|
Spiriva® Respimat® |
November 2021 |
|
||||
|
Stiolto®
Respimat® |
November 2021 |
|
||||
|
Striverdi®
Respimat® |
November 2021 |
|
||||
|
Synjardy®
Tablets |
March 2022 |
|
||||
|
Synjardy®
XR extended-release Tablets |
March 2022 |
|
||||
|
Tradjenta®
Tablets (linagliptin) |
April 2022 |
|
||||
|
Trijardy®
XR Tablets (empagliflozin, linagliptin, and metformin
hydrochloride extended-release) |
June 2021 |
|
||||
|
Twynsta® Tablets |
February 2018 |
|
|
|||
|
Viramune®
Tablets and Oral Suspension |
June 2022 |
|
||||
|
Viramune XR®Tablets (nevirapine) |
June 2022 COL10655A |
|
||||
|
|
|
|
|
|||
|
|
||||||